Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1979 1
1981 3
1982 3
1983 3
1984 2
1985 1
1987 2
1988 7
1989 4
1990 7
1991 4
1992 2
1993 1
1994 2
1995 1
1996 5
1997 5
1998 5
1999 7
2000 6
2001 12
2002 14
2003 10
2004 13
2005 15
2006 13
2007 13
2008 11
2009 16
2010 13
2011 20
2012 31
2013 33
2014 69
2015 65
2016 60
2017 66
2018 59
2019 83
2020 86
2021 84
2022 43
2023 50
2024 26

Text availability

Article attribute

Article type

Publication date

Search Results

877 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for lucia ai
Search for Luxia Ai instead (1 results)
Neuropilin-1 is a host factor for SARS-CoV-2 infection.
Daly JL, Simonetti B, Klein K, Chen KE, Williamson MK, Antón-Plágaro C, Shoemark DK, Simón-Gracia L, Bauer M, Hollandi R, Greber UF, Horvath P, Sessions RB, Helenius A, Hiscox JA, Teesalu T, Matthews DA, Davidson AD, Collins BM, Cullen PJ, Yamauchi Y. Daly JL, et al. Science. 2020 Nov 13;370(6518):861-865. doi: 10.1126/science.abd3072. Epub 2020 Oct 20. Science. 2020. PMID: 33082294 Free PMC article.
Blocking this interaction by RNA interference or selective inhibitors reduced SARS-CoV-2 entry and infectivity in cell culture. ...
Blocking this interaction by RNA interference or selective inhibitors reduced SARS-CoV-2 entry and infectivity in cell culture. ...
Denervation-activated STAT3-IL-6 signalling in fibro-adipogenic progenitors promotes myofibres atrophy and fibrosis.
Madaro L, Passafaro M, Sala D, Etxaniz U, Lugarini F, Proietti D, Alfonsi MV, Nicoletti C, Gatto S, De Bardi M, Rojas-García R, Giordani L, Marinelli S, Pagliarini V, Sette C, Sacco A, Puri PL. Madaro L, et al. Nat Cell Biol. 2018 Aug;20(8):917-927. doi: 10.1038/s41556-018-0151-y. Epub 2018 Jul 26. Nat Cell Biol. 2018. PMID: 30050118 Free PMC article.
Implementation frameworks for end-to-end clinical AI: derivation of the SALIENT framework.
van der Vegt AH, Scott IA, Dermawan K, Schnetler RJ, Kalke VR, Lane PJ. van der Vegt AH, et al. J Am Med Inform Assoc. 2023 Aug 18;30(9):1503-1515. doi: 10.1093/jamia/ocad088. J Am Med Inform Assoc. 2023. PMID: 37208863 Free PMC article. Review.
OBJECTIVE: To derive a comprehensive implementation framework for clinical AI models within hospitals informed by existing AI frameworks and integrated with reporting standards for clinical AI research. MATERIALS AND METHODS: (1) Derive a provisional implemen …
OBJECTIVE: To derive a comprehensive implementation framework for clinical AI models within hospitals informed by existing AI …
Selinexor in multiple myeloma.
Martino EA, Vigna E, Bruzzese A, Labanca C, Mendicino F, Lucia E, Olivito V, Zimbo A, Torricelli F, Neri A, Morabito F, Gentile M. Martino EA, et al. Expert Opin Pharmacother. 2024 Mar;25(4):421-434. doi: 10.1080/14656566.2024.2333376. Epub 2024 Mar 25. Expert Opin Pharmacother. 2024. PMID: 38503547 Review.
RIPK1 Expression Associates With Inflammation in Early Atherosclerosis in Humans and Can Be Therapeutically Silenced to Reduce NF-κB Activation and Atherogenesis in Mice.
Karunakaran D, Nguyen MA, Geoffrion M, Vreeken D, Lister Z, Cheng HS, Otte N, Essebier P, Wyatt H, Kandiah JW, Jung R, Alenghat FJ, Mompeon A, Lee R, Pan C, Gordon E, Rasheed A, Lusis AJ, Liu P, Matic LP, Hedin U, Fish JE, Guo L, Kolodgie F, Virmani R, van Gils JM, Rayner KJ. Karunakaran D, et al. Circulation. 2021 Jan 12;143(2):163-177. doi: 10.1161/CIRCULATIONAHA.118.038379. Epub 2020 Nov 23. Circulation. 2021. PMID: 33222501
Tyrosinase inhibitors as potential antibacterial agents.
Yuan Y, Jin W, Nazir Y, Fercher C, Blaskovich MAT, Cooper MA, Barnard RT, Ziora ZM. Yuan Y, et al. Eur J Med Chem. 2020 Feb 1;187:111892. doi: 10.1016/j.ejmech.2019.111892. Epub 2019 Nov 18. Eur J Med Chem. 2020. PMID: 31810785 Review.
In the past decade many natural and synthetic tyrosinase inhibitors have been evaluated, with many reported to also possess intrinsic antibacterial activity. ...This review focuses on the antibacterial activity of natural and synthetic tyrosinase inhibitors reported …
In the past decade many natural and synthetic tyrosinase inhibitors have been evaluated, with many reported to also possess intrinsic …
877 results